• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON BD PEN II ORGANON PUREGON PEN SECOND GEN.; PEN NEEDLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON BD PEN II ORGANON PUREGON PEN SECOND GEN.; PEN NEEDLE Back to Search Results
Catalog Number 47289378
Device Problems Use of Device Problem (1670); Inaccurate Delivery (2339)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 03/21/2019
Event Type  malfunction  
Manufacturer Narrative
For oem manufacturing sites: in this mdr, bd corporate headquarters in (b)(4).A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that the pen was not functioning with a bd pen ii organon puregon pen second gen.The following information was provided by the initial reporter: the client informs that his wife is undergoing treatment.She reports that she used the drug for the first time now in (b)(6) (she could not tell the exact date) and reports that the doctor prescribed 75 units to use for 5 days the first time and reported that using a 300 ampoule units with this amount of 75 units for 5 days was still left over and on the last day of treatment she made use of the rest of the medicine that was still in the ampoule.And the second time the patient took medication, the doctor prescribed 150 units of 3 days, reports that you purchased one ampoule of the drug and the clinic sold another already opened ampoule of 300 units containing only 150 units to give the exact amount to be used for 3 days, but the rapporteur reported that in only 1 ampoule of 300 units the patient performed the treatment for the 3 days and there remained about 10 millimeters more to the other ampoule that was in half.The rapporteur said that the patient knows how to use the medicine and believes that the pen is malfunction.
 
Event Description
It was reported that the pen was not functioning with a bd pen ii organon puregon pen second gen.The following information was provided by the initial reporter: the client informs that his wife is undergoing treatment.She reports that she used the drug for the first time now in march (she could not tell the exact date) and reports that the doctor prescribed 75 units to use for 5 days the first time and reported that using a 300 ampoule units with this amount of 75 units for 5 days was still left over and on the last day of treatment she made use of the rest of the medicine that was still in the ampoule.And the second time the patient took medication, the doctor prescribed 150 units of 3 days, reports that you purchased one ampoule of the drug and the clinic sold another already opened ampoule of 300 units containing only 150 units to give the exact amount to be used for 3 days, but the rapporteur reported that in only 1 ampoule of 300 units the patient performed the treatment for the 3 days and there remained about 10 millimeters more to the other ampoule that was in half.The rapporteur said that the patient knows how to use the medicine and believes that the pen is malfunction.
 
Manufacturer Narrative
H.6.Investigation: zero (0) samples were provided to bd medical ¿ pharmaceutical system (bdm-ps) for analysis.Bdm-ps performed a batch history record¿s review (bhr) including a review of all data collected during in process and quality inspections.The batch involved in this complaint meets all acceptable quality levels (aql¿s), was manufactured and released according to applicable procedures and specifications.Since the sample was not received, investigation cannot be performed as a sample is required to investigate further.Based on investigation conclusion, bdm-ps was not able to confirm the symptom perceived by customer or correlate this symptom with a potential cause linked to bd process.H3 other text : see h.10.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD PEN II ORGANON PUREGON PEN SECOND GEN.
Type of Device
PEN NEEDLE
Manufacturer (Section D)
BECTON DICKINSON
1 becton drive
franklin lakes NJ 07417
MDR Report Key8629713
MDR Text Key146364434
Report Number2243072-2019-00979
Device Sequence Number1
Product Code NSC
Combination Product (y/n)N
PMA/PMN Number
N/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,distributor,foreign
Type of Report Initial,Followup
Report Date 07/03/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/21/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Catalogue Number47289378
Device Lot Number16025002
Date Manufacturer Received05/06/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-